Latest profit margin for Eyenovia: -4682.24% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Eyenovia (EYEN) currently reports a profit margin of -4682.24% as of June 2026. That compares with -90051.5% in the prior-year period — up 94.8% year over year. That is below the Healthcare sector average of 13.71%. Use the charts on this page to explore Eyenovia's profit margin history and peer comparisons.
Eyenovia's profit margin increased from -90051.5% to -4682.24% — a 94.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Eyenovia's profit margin of -4682.24% is lower than the Healthcare sector average of 13.71%. That is roughly 34249.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Eyenovia's current -4682.24% should be judged against Healthcare norms (sector average: 13.71%) and against EYEN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -4682.24%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.71%. From there, open related valuation or income-statement pages for Eyenovia, and consider following EYEN for alerts when major investors trade the stock.